The crystal structure of human ferroptosis suppressive protein 1 in complex with flavin adenine dinucleotide and nicotinamide adenine nucleotide

Abstract

Ferroptosis is a recently discovered form of regulated cell death characterized by its distinct dependence on iron and the peroxidation of lipids within cellular membranes. Ferroptosis plays a crucial role in physiological and pathological situations and has attracted the attention of numerous scientists. Ferroptosis suppressive protein 1 (FSP1) is one of the main regulators that negatively regulates ferroptosis through the GPX4-independent FSP1–CoQ10–NAD(P)H axis and is a potential therapeutic target for ferroptosis-related diseases. However, the crystal structure of FSP1 has not been resolved, which hinders the development of therapeutic strategies targeting FSP1. To unravel this puzzle, we purified the human FSP1 (hFSP1) protein using the baculovirus eukaryotic cell expression system and solved its crystal structure at a resolution of 1.75 Å. Furthermore, we evaluated the oxidoreductase activity of hFSP1 with NADH as the substrate and identified E156 as the key amino acid in maintaining hFSP1 activity. Interestingly, our results indicated that hFSP1 exists and functions in a monomeric state. Mutagenesis analysis revealed the critical role of the C-terminal domain in the binding of substrate. These findings significantly enhance our understanding of the functional mechanism of FSP1 and provide a precise model for further drug development.

Keywords

6-OH-FAD / ferroptosis / FSP1 / NADH / oxidoreductase / structure

References

1	BR Stockwell. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401-2421.
2	MS D'Arcy. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582-592.
3	R Singh, A Letai, K Sarosiek. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20(3):175-193.
4	G Zhang, J Wang, Z Zhao, et al. Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections. Cell Death Dis. 2022;13(7):1-14.
5	X Jiang, BR Stockwell, M Conrad. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266-282.
6	D Tang, X Chen, R Kang, G Kroemer. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107-125.
7	L Jiang, N Kon, T Li, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57-62.
8	W Wang, M Green, JE Choi, et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270-274.
9	Y Lv, D Chen, X Tian, et al. Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis. J Transl Med. 2023;21(1):293.
10	BR Stockwell, X Jiang. A physiological function for ferroptosis in tumor suppression by the immune system. Cell Metab. 2019;30(1):14-15.
11	G Lei, L Zhuang, B Gan. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381-396.
12	HF Yan, T Zou, QZ Tuo, et al. Ferroptosis: mechanisms and links with diseases. Sig Transduct Target Ther. 2021;6(1):49.
13	Y Chen, ZM Fang, X Yi, X Wei, DS Jiang. The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis. 2023;14(3):1-13.
14	S Van Coillie, E Van San, I Goetschalckx, et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat Commun. 2022;13(1):1046.
15	MA Greenough, DJR Lane, R Balez, et al. Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations. Cell Death Differ. 2022;29(11):2123-2136.
16	ZL Wang, L Yuan, W Li, JY Li. Ferroptosis in Parkinson's disease: glia–neuron crosstalk. Trends Mol Med. 2022;28(4):258-269.
17	S Song, Z Su, N Kon, et al. ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington's disease. Genes Dev. 2023;37(5-6):204-217.
18	Y Mi, X Gao, H Xu, Y Cui, Y Zhang, X Gou. The emerging roles of ferroptosis in Huntington's disease. Neuromol Med. 2019;21(2):110-119.
19	CO Reichert, FA de Freitas, J Sampaio-Silva, et al. Ferroptosis mechanisms involved in neurodegenerative diseases. Int J Mol Sci. 2020;21(22):8765.
20	C Zhang, X Liu, S Jin, Y Chen, R Guo. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.
21	L Ni, C Yuan, X Wu. Targeting ferroptosis in acute kidney injury. Cell Death Dis. 2022;13(2):1-11.
22	J Chen, X Li, C Ge, J Min, F Wang. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29(3):467-480.
23	J Wu, Y Wang, R Jiang, et al. Ferroptosis in liver disease: new insights into disease mechanisms. Cell Death Discov. 2021;7(1):1-9.
24	S Feng, D Tang, Y Wang, et al. The mechanism of ferroptosis and its related diseases. Mol Biomed. 2023;4(1):33.
25	F Ursini, M Maiorino. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175-185.
26	S Doll, FP Freitas, R Shah, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693-698.
27	K Bersuker, JM Hendricks, Z Li, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688-692.
28	K Weaver, R Skouta. The selenoprotein glutathione peroxidase 4: from molecular mechanisms to novel therapeutic opportunities. Biomedicines. 2022;10(4):891.
29	W Li, L Liang, S Liu, H Yi, Y Zhou. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29(9):753-764.
30	J Lee, JL Roh. Unleashing ferroptosis in human cancers: targeting ferroptosis suppressor protein 1 for overcoming therapy resistance. Antioxidants (Basel). 2023;12(6):1218.
31	T Nakamura, C Hipp, A Santos Dias Mour?o, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619(7969):371-377.
32	TN Xavier da Silva, C Schulte, AN Alves, HM Maric, JP Friedmann Angeli. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell Death Dis. 2023;14(4):1-9.
33	P Koppula, G Lei, Y Zhang, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13(1):2206.
34	MR Jackson, PJ Loll, MS Jorns. X-ray structure of human sulfide:quinone oxidoreductase: insights into the mechanism of mitochondrial hydrogen sulfide oxidation. Structure. 2019;27(5):794-805.e4.
35	M Marcia, U Ermler, G Peng, H Michel. The structure of Aquifex aeolicus sulfide:quinone oxidoreductase, a basis to understand sulfide detoxification and respiration. Proc Natl Acad Sci USA. 2009;106(24):9625-9630.
36	MJ Maté, M Ortiz-Lombardía, B Boitel, et al. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Mol Biol. 2002;9(6):442-446.
37	S Zhang, S Gou, Q Zhang, X Yong, B Gan, D Jia. FSP1 oxidizes NADPH to suppress ferroptosis. Cell Res. 2023;33(12):967-970. Published online September 22, 2023:1-4.
38	Y Lv, C Liang, Q Sun, et al. Structural insights into FSP1 catalysis and ferroptosis inhibition. Nat Commun. 2023;14(1):5933.
39	E Mishima, J Ito, Z Wu, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608(7924):778-783.
40	CM Bebber, S von Karstedt. FSP1 inhibition: pick your pocket. Nat Struct Mol Biol. 2023;30(11):1618-1619.
41	F Müller, JKM Lim, CM Bebber, et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 2023;30(2):442-456.
42	S Yuan, S Xi, H Weng, et al. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer. Cell Death Differ. 2023;30(12):2477-2490. Published online October 30, 2023.
43	J Gong, Y Liu, W Wang, et al. TRIM21-promoted FSP1 plasma membrane translocation confers ferroptosis resistance in human cancers. Adv Sci (Weinh). 2023;10(29):2302318.
44	LR Stein, ichiro ImaiS. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab. 2012;23(9):420-428.
45	E Mishima, T Nakamura, J Zheng, et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature. 2023;619(7968):E9-E18.
46	T Nakamura, E Mishima, N Yamada, et al. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation. Nat Struct Mol Biol. 2023;30(11):1806-1815.
47	P Ferreira, R Villanueva, M Martínez-Júlvez, et al. Structural insights into the coenzyme mediated monomer-dimer transition of the pro-apoptotic apoptosis inducing factor. Biochemistry. 2014;53(25):4204-4215.
48	D Tang, J Sheng, L Xu, et al. Cryo-EM structure of C9ORF72–SMCR8–WDR41 reveals the role as a GAP for Rab8a and Rab11a. Proc Natl Acad Sci. 2020;117(18):9876-9883.
49	Z Otwinowski, W Minor. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307-326.
50	J Jumper, R Evans, A Pritzel, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589.
51	M Varadi, S Anyango, M Deshpande, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439-D444.
52	PD Adams, PV Afonine, G Bunkóczi, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(2):213-221. Pt.
53	P Emsley, K Cowtan. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(12):2126-2132. Pt. Pt 1.
54	PyMOL | pymol.org.
55	CS Bond. TopDraw: a sketchpad for protein structure topology cartoons. Bioinformatics. 2003;19(2):311-312.